Xunfei Healthcare Technology Co., Ltd. (Xunfei Healthcare; HKEX: 02506) disclosed that Imaging Union Cloud Health Technology Co., Ltd. (“Imaging Union Cloud”) has become a connected subsidiary under Hong Kong Listing Rule 14A.16 following an equity transfer on 12 June 2026. The change activates continuing connected-transaction reporting obligations for three pre-existing framework agreements between the two groups.

Key Transaction • Anhui Yanzhi Technology Co., Ltd. (“Anhui Yanzhi”) acquired a 20.99% stake in Imaging Union Cloud from Yilian Yunxiang, Youngy Health and Chongshan Yuanwei. • Post-transaction ownership of Imaging Union Cloud: Xunfei Healthcare 51.00%, Anhui Yanzhi 20.99%, iFlytek Yunchuang 7.03%, Yilian Yunxiang 16.97% and Youngy Health 4.02%. • Liu Qingfeng, a director of Xunfei Healthcare, holds 69.52% of Anhui Yanzhi, rendering Imaging Union Cloud a connected subsidiary.

Impacted Continuing Connected Transactions 1. Product and Service Supply Framework Agreement – Current term: until 31 December 2026 (renewed annually since 1 August 2021). – 2026 cap: RMB 40.00 million. – Year-to-date utilisation: RMB 7.10 million. – Covers operating materials, IT and cloud services, and administrative support, priced no less favourably than market terms.

2. Bidding Project Cooperation Framework Agreement – Validity: 29 May 2026 – 31 December 2026. – 2026 subcontracting cap: RMB 100.00 million. – Key contract to date: RMB 43.16 million technical service package for the National AI Application Pilot Base (Primary Healthcare).

3. Financial Assistance Agreement – Fund lending facility (effective to 31 Dec 2027): up to RMB 10.00 million; RMB 7.00 million drawn, fixed interest rate 2.11% per annum. – Corporate guarantees (18 May 2026 – 17 May 2027): aggregate cap of RMB 80.00 million across five financial institutions.

Rationale Xunfei Healthcare cites enhanced resource allocation, cost efficiencies and improved project-bidding competitiveness as primary motivations. Internal provisioning of technology, cloud, HR and marketing services is expected to lower operating costs, while centralised financing and guarantees aim to reduce subsidiary funding expenses and bolster project execution.

Regulatory Outlook Under Listing Rule 14A.60, Xunfei Healthcare must conduct annual reviews and publish requisite disclosures for all transactions with Imaging Union Cloud. Any renewal or modification of the agreements will necessitate full compliance with HKEX reporting and, where applicable, independent shareholder approval requirements.

Company Profile Xunfei Healthcare positions itself as a leading AI medical-technology firm in China, focusing on large-scale medical language models and intelligent healthcare solutions for public and private sector clients.